Completed

1

10

US

carfilzomib, Kyprolis, PR-171, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, doxorubicin hydrochloride, ADM, ADR, Adria, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, leucovorin calcium, CF, CFR, LV, methylprednisolone, Depo-Medrol, Medrol, MePRDL, Solu-Medrol, Wyacort, rituximab, IDEC-C2B8, IDEC-C2B8 monoclonal antibody, Mabthera, MOAB IDEC-C2B8, Rituxan, laboratory biomarker analysis

Mehrdad Abedi, MD, Amgen

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia

12/17

01/18